Thalidomide as a nitric oxide synthase inhibitor and its structural development

Chemical and Pharmaceutical Bulletin

Volumn 52, Issue 4, 2004, Pages 498-499

  Shimazawa, Rumiko ^a,b   Sano, Hiroko ^a   Tanatani, Aya ^a   Miyachi, Hiroyuki ^a   Hashimoto, Yuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Inhibitor; Nitric oxide synthase (NOS); Structural development; Thalidomide

Indexed keywords

NITRIC OXIDE SYNTHASE INHIBITOR; THALIDOMIDE; DRUG DERIVATIVE; ENZYME INHIBITOR; NITRIC OXIDE SYNTHASE;

ARTICLE; DRUG ACTIVITY; DRUG STRUCTURE; ENZYME INHIBITION; CHEMISTRY; DRUG ANTAGONISM; KINETICS; STRUCTURE ACTIVITY RELATION;

ENZYME INHIBITORS; KINETICS; NITRIC OXIDE SYNTHASE; STRUCTURE-ACTIVITY RELATIONSHIP; THALIDOMIDE;

EID: 3142655571     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.52.498     Document Type: Article

References (24)

1. Hales B. F., Nat. Med., 5, 489-490 (1999).
2. Hashimoto Y., Curr. Med. Chem., 5, 163-178 (1998).
3. Hashimoto Y., Bioorg. Med. Chem., 10, 461-479 (2002).
4. Calabrese L., Fleisher A. B., Am. J. Med., 108, 487-491 (2000).
5. Miyachi H., Azuma A., Ogasawara A, Uchimura E., Watanabe N., Kobayashi Y., Kato F., Kato M., Hashimoto Y., J. Med. Chem., 40, 2858-2865 (1997).
6. Miyachi H., Ogasawara A., Azuma A., Hashimoto Y., Bioorg. Med. Chem., 5, 2095-2102 (1997).
7. Shibata Y., Sasaki K., Hashimoto Y., Iwasaki S., Chem. Pharm. Bull., 44, 156-162 (1996).
8. Miyachi H., Azuma A., Kitamoto T., Hayashi K., Kato S., Koga M., Sato B., Hashimoto Y., Bioorg. Med. Chem. Lett., 7, 1483-1488 (1997).
9. Ishioka T., Kubo A., Koiso Y., Nagasawa K., Itai A., Hashimoto Y., Bioorg. Med. Chem., 10, 1555-1566 (2002).
10. Miyachi H., Kato M., Kato F., Hashimoto Y., J. Med. Chem., 41, 263-265 (1998).
11. Komoda M., Kakuta H., Takahashi H., Fujimoto Y., Kadoya S., Kato F., Hashimoto Y., Bioorg. Med. Chem., 9, 121-131 (2001).
12. Shimazawa R., Takayama H., Kato F., Kato M., Hashimoto Y., Bioorg. Med. Chem. Lett., 9, 559-562 (1999).
13. Shimazawa R., Takayama H., Fujimoto Y., Komoda M., Dodo K., Yamasaki R., Shirai R., Koiso Y., Miyata K., Kato F., Kato M., Miyachi H., Hashimoto Y., J. Enzyme Inhibit., 14, 259-275 (1999).
14. Kakuta H., Tanatani A., Nagasawa K., Hashimoto Y., Chem. Pharm. Bull., 51, 1273-1282 (2003).
15. Sou S., Mayumi S., Takahashi H., Yamasaki R., Kadoya S., Sodeoka M., Hashimoto Y., Bioorg. Med. Chem. Lett., 10, 1081-1084 (2000).
16. Takahishi H., Sou S., Yamasaki R., Sodeoka M., Hashimoto Y., Chem. Pharm. Bull., 48, 1494-1499 (2000).
17. Kita T., Takahashi H., Hashimoto Y., Biol. Pharm. Bull., 24, 860-862 (2001).
18. Noguchi T., Shimazawa R., Nagasawa K. Hashimoto Y., Bioorg. Med. Chem. Lett., 12, 1043-1046 (2002).
19. Suizu M., Muroya Y., Kakuta H., Kagechika H., Tanatani A., Nagasawa K., Hashimoto Y., Chem. Pharm. Bull., 51, 1098-1102 (2003).
20. Moncala S., Palmer R. M. J., Higgs E. A., Pharmacol. Rev., 43, 109-142 (1991).
21. In this experiment, we used nNOS (Cayman, No. 60870).
22. Ichimori K., Stuehr D. J., Atkinson R. N., King S. B., J. Med. Chem., 42, 1842-1848 (1999).
23. Kakuta H., Takahashi H., Sou S., Kita T., Nagasawa K., Hashimoto Y., Recent Res. Devel. Medicinal Chem., 1, 187-211 (2001).
24. Takahashi H., Komoda M., Kakuta H., Hashimoto Y., Yakugaku Zasshi, 120, 909-921 (2000).